As per Stock Exchange Announcement No. 12/2007 Coloplast will continue the share buy-back under a new programme for the period until 30 September 2007. Under this programme the following transactions have been executed during the period 3.9.07 - 7.9.07 (see attached PDF).
Recommended Reading
-
The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company’s next-generation device and will be...
Read More -
2025/26Interim financial results, H1 2025/261 October 2025 - 31 March 2026 Coloplast delivered Q2 organic growth of 6% and 6% EBIT growth1 in constant currencies. Strong quarter in Chronic Care and...
Read More